Recent Advances in the Pharmacotherapy of Infantile Spasms Raili Riikonen Current Opinion 07 February 2014 Pages: 279 - 290
The Evidence for a Beneficial Role of Vitamin A in Multiple Sclerosis Yara Dadalti FragosoPatrick N. StoneyPeter J. McCaffery Leading Article 21 February 2014 Pages: 291 - 299
Psychopharmacological Treatment of Neurocognitive Deficits in People with Schizophrenia: A Review of Old and New Targets Anthony O. AhmedIshrat A. Bhat Review Article 14 February 2014 Pages: 301 - 318
The Mu-Opioid Receptor Agonist/Noradrenaline Reuptake Inhibition (MOR–NRI) Concept in Analgesia: The Case of Tapentadol Thomas M. TzschentkeThomas ChristophBabette Y. Kögel Review Article 28 February 2014 Pages: 319 - 329
Role of Lithium Augmentation in the Management of Major Depressive Disorder Michael BauerMazda AdliMaximilian Pilhatsch Review Article 05 March 2014 Pages: 331 - 342
Pharmacological Approaches to Reducing Craving in Patients with Alcohol Use Disorders Carolina L. Haass-KofflerLorenzo LeggioGeorge A. Kenna Review Article 27 February 2014 Pages: 343 - 360
Assessment of the Abuse Liability of a Dual Orexin Receptor Antagonist: A Crossover Study of Almorexant and Zolpidem in Recreational Drug Users Hans G. CruzPetra HoeverJasper Dingemanse Original Research Article 14 March 2014 Pages: 361 - 372
Dimethyl Fumarate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis Celeste B. BurnessEmma D. Deeks Adis Drug Evaluation 13 March 2014 Pages: 373 - 387